Login to Your Account



Today Scorpions – Tomorrow Pit Vipers and Spiders

By Tom Wall


Friday, August 5, 2011
Rare Disease Therapeutics Inc., a Franklin, Tenn.-based company focused on developing orphan products, has won FDA approval for Anascorp, the first specific treatment for a scorpion sting by Centruroides scorpions in the U.S.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription